Himanshu Kumar

Dr. Himanshu Kumar

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2025 in Discover Molecules
Verified
Journal Article
Open access
PDF file
APAditya Pathak
Aditya Pathak
RTRadhika Theagarajan
Radhika Theagarajan
MRMuhammad Miftakhur Rizqi
Muhammad Miftakhur Rizqi
ANAri Satia Nugraha
Ari Satia Nugraha
TBTridip Boruah
Tridip Boruah
Pankaj KumarPankaj Kumar
Pankaj Kumar
The integration of artificial intelligence (AI) with bioinformatics has initiated a transformative shift in drug discovery, redefining how pharmaceutical research and development are conducted. This review examines both the current state and emerging prospects of AI-driven strategies across the drug discovery pipeline, from target identification and molecular design to clinical applications. Advances in machine learning, deep learning, graph neural networks, transformers, foundation models, and quantum computing have shown remarkable potential in overcoming long-standing bottlenecks of conventional drug development, which on average requires 12.5 years and over $2 billion to bring a single drug to market. The AI in pharmaceuticals market, valued at $1.8 billion in 2023, is projected to reach $13.1 billion by 2030, reflecting a compound annual growth rate of 18.8%. Landmark breakthroughs such as AlphaFold, which has generated over 200 million predicted protein structures and more than 20,000 citations, have established new paradigms in structural biology and drug design, while emerging tools like RFdiffusion and AlphaFold3 further extend capabilities into de novo protein design and multi-omics integration. AI-enabled workflows have demonstrated the ability to compress discovery timelines from five years to as little as 12–18 months and reduce costs by up to 40%. Despite these advances, significant challenges remain, including issues of data quality and bias, model transparency and interpretability, computational resource demands, and ethical concerns regarding privacy and algorithmic fairness. This review synthesizes findings from recent studies to provide a roadmap for the responsible and reproducible integration of AI into bioinformatics and drug discovery, while outlining critical gaps and future research priorities essential for clinical translation.

13 January 2026 in Symbiosis
Verified
Journal Article
Closed access
PDF file
PKPankaj Kumar
Pankaj Kumar
APAditya Pathak
Aditya Pathak
HKHimanshu Kumar
Himanshu Kumar
GSGarima Sharma
Garima Sharma
PMPrashant Mishra
Prashant Mishra
KKKamal Khilari
Kamal Khilari

26 September 2025 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
APAditya Pathak
Aditya Pathak
Pankaj KumarPankaj Kumar
Pankaj Kumar
HKHimanshu Kumar
Himanshu Kumar
JSJitender Singh
Jitender Singh
MBMahesh Kumar Bharti
Mahesh Kumar Bharti
KKKamal Khilari
Kamal Khilari

26 November 2025 in All Life
Verified
Journal Article
Open access
HKHimanshu Kumar
Himanshu Kumar
Pankaj KumarPankaj Kumar
Pankaj Kumar
APAditya Pathak
Aditya Pathak
Malyaj R. PrajapatiMalyaj R. Prajapati
Malyaj R. Prajapati
MBMahesh Kumar Bharti
Mahesh Kumar Bharti
SKSatendra Kumar
Satendra Kumar

10 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
HKHimanshu Kumar
Himanshu Kumar
Pankaj KumarPankaj Kumar
Pankaj Kumar
Malyaj R. PrajapatiMalyaj R. Prajapati
Malyaj R. Prajapati
MBMahesh Kumar Bharti
Mahesh Kumar Bharti
SPSatya Prakash
Satya Prakash
SKSatendra Kumar
Satendra Kumar
Sugarcane (Saccharum officinarum L.) is a vital agro-industrial crop, significantly contributing to the economy of many tropical and subtropical regions, including India. The country is one of the largest producers of sugarcane, with Uttar Pradesh leading as a prominent state in terms of sugarcane cultivation. Sugarcane is not only a primary source of sugar but also a renewable source of bioenergy, ethanol, and other industrial products. However, the productivity of sugarcane varies widely, with some fields demonstrating exceptionally high yields, while others yield poorly, despite being subjected to similar agronomic practices. One of the key factors contributing to this yield disparity, which has gained attention in recent years, is the rhizospheric microbiome. The rhizosphere, the narrow region of soil influenced by root secretions and associated soil microorganisms, plays a crucial role in plant growth and development. This study investigates the composition of rhizosphere microbiota in sugarcane (Saccharum officinarum) using 16S rRNA high-throughput sequencing. By analysing the microbial communities associated with sugarcane rhizosphere, we aim to explain the interactions between plants and their microbial partners that contribute to growth and development. According to our findings, the microbial population is dominated and diversified, with bacterial phyla like Pseudomonadota, Bacillota, Bacteroidota, Candidatus, Saccharibacteria, Actinomycetota, Myxococcota, Acidobacteriota, and Planctomycetota predominating. Furthermore, we demonstrate that specific microbial taxa are consistently associated with high and low yielding sugarcane, suggesting their potential as bioindicators for crop health and productivity. This study highlights the significance of rhizosphere bacteria in the context of sustainable sugarcane farming. In order to increase sugarcane resilience and yield, this study lays the groundwork for future investigations into the advantageous characteristics of rhizosphere bacteria.

18 April 2026 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
HKHimanshu Kumar
Himanshu Kumar
Pankaj KumarPankaj Kumar
Pankaj Kumar
MPMalyaj R. Prajapati
Malyaj R. Prajapati
MBMahesh Kumar Bharti
Mahesh Kumar Bharti
SPSatya Prakash
Satya Prakash
NKNeelesh Kapoor
Neelesh Kapoor
Sugarcane (Saccharum officinarum L.) is an important cash crop in India, and its cultivation contributes significantly to the country's economy by producing sugar, bioethanol, and other valuable by-products. The rhizosphere microbiome plays a vital role in nutrient cycling, plant health, and soil functioning. Hence, the soil microbiome associated with sugarcane cultivation plays a crucial role in nutrient cycling, plant health, and overall ecosystem functioning. However, information on the composition and diversity of bacterial communities in sugarcane rhizosphere soils of Uttar Pradesh remains limited. In different places, the outcomes of different cropping systems on the microbiome differ, affecting crop health and productivity. In the present study, bacterial diversity was characterized using 16S rRNA amplicon sequencing across different locations. The results revealed distinct variations in microbial community composition among sites, as supported by beta diversity analysis. Dominant bacterial phyla included Pseudomonadota, Bacillota, Bacteroidota, Actinomycetota, and Acidobacteriota, indicating their potential roles in rhizosphere functioning. These findings provide insights into the structure of sugarcane-associated microbial communities and highlight their importance in sustainable crop production.